Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model
Authors:
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (4) , 1316-1323
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitroAngiogenesis, 2001
- Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cellsProceedings of the National Academy of Sciences, 1998
- Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)Proceedings of the National Academy of Sciences, 1998
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma CellsJournal of Biological Chemistry, 1996
- Macrophages and angiogenesisJournal of Leukocyte Biology, 1994
- Macrophage-induced angiogenesis is mediated by tumour necrosis factor-αNature, 1987
- Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.Proceedings of the National Academy of Sciences, 1987
- Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile womenFertility and Sterility, 1982
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavityAmerican Journal of Obstetrics and Gynecology, 1927